← Bausch Health Companies Inc. BHC
Market Price
$6.51
Market Cap
$2.37B
P/E Ratio
15.50
Revenue (FY 2025)
↑6.7% YoY
$10.27B
3-Yr CAGR: 8.1%
Net Income
↑441.3% YoY
$157.00M
Net Margin: 1.5%
Free Cash Flow
↓-20.4% YoY
$1.00B
FCF Yield: 42.36%
EPS (Diluted)
↑423.1% YoY
$0.42
Basic: $0.42
Return on Equity
Efficiency
N/A
ROA: 18.4%
⚡ N/A due to negative equity (share buybacks or other)
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (BHC)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $9,674.0M | — | $7,102.0M | $-2,409.0M | — | $-6.94 | — | $2,087.0M | $1,852.0M | — |
| FY 2017 | $8,724.0M | -9.8% | $6,218.0M | $2,404.0M | +199.8% | $6.83 | +198.4% | $2,290.0M | $2,119.0M | +14.4% |
| FY 2018 | $8,380.0M | -3.9% | $6,029.0M | $-4,148.0M | -272.5% | $-11.81 | -272.9% | $1,501.0M | $1,344.0M | -36.6% |
| FY 2019 | $8,601.0M | +2.6% | $6,251.0M | $-1,788.0M | +56.9% | $-5.08 | +57.0% | $1,501.0M | $1,231.0M | -8.4% |
| FY 2020 | $8,027.0M | -6.7% | $5,778.0M | $-560.0M | +68.7% | $-1.58 | +68.9% | $1,111.0M | $809.0M | -34.3% |
| FY 2021 | $8,434.0M | +5.1% | $6,040.0M | $-948.0M | -69.3% | $-2.64 | -67.1% | $1,426.0M | $1,157.0M | +43.0% |
| FY 2022 | $8,124.0M | -3.7% | $5,760.0M | $-225.0M | +76.3% | $-0.62 | +76.5% | $-728.0M | $-946.0M | -181.8% |
| FY 2023 | $8,757.0M | +7.8% | $6,198.0M | $-592.0M | -163.1% | $-1.62 | -161.3% | $1,032.0M | $817.0M | +186.4% |
| FY 2024 | $9,625.0M | +9.9% | $6,843.0M | $-46.0M | +92.2% | $-0.13 | +92.0% | $1,597.0M | $1,260.0M | +54.2% |
| FY 2025 | $10,266.0M | +6.7% | $7,253.0M | $157.0M | +441.3% | $0.42 | +423.1% | $1,400.0M | $1,003.0M | -20.4% |
Valuation
Market Price
$6.51
Market Cap
$2.37B
Enterprise Value
$21.88B
P/E Ratio
15.50
P/B Ratio
N/A
FCF Yield
42.36%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
70.65%
Operating Margin
17.66%
Net Margin
1.53%
Return on Equity (ROE)
N/A (Negative Equity)
Return on Assets (ROA)
18.43%
Asset Turnover
12.05x
Revenue 3-Yr CAGR
8.11%
Financial Health & Liquidity
Current Ratio
0.25
Cash Ratio
0.39
Debt / Equity
-37.576
Debt / Assets
24.433
Cash & Equivalents
$1.31B
Total Debt
$20.82B
Book Value / Share
$-1.48
Cash Flow Efficiency
Operating Cash Flow
$1.40B
Capital Expenditures (CapEx)
$397.00M
Free Cash Flow
$1.00B
OCF / Revenue
13.64%
FCF / Revenue
9.77%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$0.42
EPS (Basic)
$0.42
Dividends / Share
N/A
Book Value / Share
$-1.48
EPS YoY Growth
423.08%
Balance Sheet (FY 2025)
Total Assets
$852.00M
Total Liabilities
$3.34B
Stockholders' Equity
-$554.00M
Current Assets
$852.00M
Current Liabilities
$3.34B